Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Hidden heroes of healthcare: Reaching NPs and PAs
Nurse practitioners and physician assistants are vital players in US healthcare, yet the industry often overlooks them.
Read more
Utilising data lakes in pharma
Pharma’s data lake is increasing in size. Read to find out how the industry can use it to its best advantage.
A blockchain solution for pharma
How can blockchain-based technology advance business development and investment?
5 minutes with Gen Li, President, Phesi
5 minutes with Gen Li, President of clinical trial database company Phesi.
Editor's Letter: December 2022
Pharma should double down on its patient centricity efforts to help tackle inequalities in 2023 and beyond, says Helena Beer.
Challenging the postcode health lottery
A postcode can determine health outcomes more than genetics. How can pharma help to solve the postcode lottery?
Turning patient insights into action
Pharma endeavours to drive positive action from patient insights. Read to find out how they could improve their methodologies and outcomes.
Mitigating the rare disease RWD deficit
RWD for rare diseases is scarce, but pharma can work to leverage existing processes and build trust to enhance the scope of available data.
Is the generics and biosimilars sector at risk of collapse?
Generics and biosimilars are crucial to healthcare worldwide, but there are challenges in getting these medicine to patients.
Loading posts...
« Previous
1
…
9
10
11
12
13
…
33
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View